Clonal cell populations unresponsive to radiosensitization induced by telomerase inhibition

Biochemical and Biophysical Research Communications

Volumn 402, Issue 2, 2010, Pages 198-202

  Ju, Yeun Jin ^a   Shin, Hyun Jin ^a   Park, Jeong Eun ^a   Juhn, Kyoung Mi ^a   Woo, Seon Rang ^a   Kim, Hee Young ^a   Han, Young Hoon ^a   Hwang, Sang Gu ^a   Hong, Sung Hee ^a   Kang, Chang Mo ^a   Yoo, Young Do ^b   Park, Won Bong ^c   Cho, Myung Haing ^d   Park, Gil Hong ^b   Lee, Kee Ho ^a  

^a Korea Institute of Radiation and Medical Science   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Seoul Women University   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

Chromosomal end to end fusion; Radiosensitization; Telomere; Telomere length

Indexed keywords

PROTEIN P53; TELOMERASE;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL CLONING; CELL POPULATION; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLAST; GENE LOCUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; RADIOSENSITIZATION; TELOMERE;

ANIMALS; CLONE CELLS; FIBROBLASTS; MICE; MICE, MUTANT STRAINS; RADIATION TOLERANCE; TELOMERASE; TELOMERE;

EID: 78149470396     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.09.091     Document Type: Article

References (26)

1. Bernier J., Hall E.J., Giaccia A. Radiation oncology: a century of achievements. Nat. Rev. Cancer 2004, 4:737-747.
2. Tofilon P.J., Camphausen K. Molecular targets for tumor radiosensitization. Chem. Rev. 2009, 109:2974-2988.
3. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., Coviello G.M., Wright W.E., Weinrich S.L., Shay J.W. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266:2011-2015.
4. Shay J.W., Wright W.E. Telomerase activity in human cancer. Curr. Opin. Oncol. 1996, 8:66-71.
5. Cabuy E., Newton C., Joksic G., Woodbine L., Koller B., Jeggo P.A., Slijepcevic P. Accelerated telomere shortening and telomere abnormalities in radiosensitive cell lines. Radiat. Res. 2005, 164:53-62.
6. Rubio M.A., Kim S.H., Campisi J. Reversible manipulation of telomerase expression and telomere length. Implications for the ionizing radiation response and replicative senescence of human cells. J. Biol. Chem. 2002, 277:28609-28617.
7. McIlrath J., Bouffler S.D., Samper E., Cuthbert A., Wojcik A., Szumiel I., Bryant P.E., Riches A.C., Thompson A., Blasco M.A., Newbold R.F., Slijepcevic P. Telomere length abnormalities in mammalian radiosensitive cells. Cancer Res. 2001, 61:912-915.
8. Slijepcevic P. Is there a link between telomere maintenance and radiosensitivity?. Radiat. Res. 2004, 161:82-86.
9. Zhong Y.H., Liao Z.K., Zhou F.X., Xie C.H., Xiao C.Y., Pan D.F., Luo Z.G., Liu S.Q., Zhou Y.F. Telomere length inversely correlates with radiosensitivity in human carcinoma cells. Biochem. Biophys. Res. Commun. 2008, 367:84-89.
10. Wong K.K., Chang S., Weiler S.R., Ganesan S., Chaudhuri J., Zhu C., Artandi S.E., Rudolph K.L., Gottlieb G.J., Chin L., Alt F.W., Depinho R.A. Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation. Nat. Genet. 2000, 26:85-88.
11. Goytisolo F.A., Samper E., Martín-Caballero J., Finnon P., Herrera E., Flores J.M., Bouffler S.D., Blasco M.A. Short telomeres result in organismal hypersensitivity to ionizing radiation in mammals. J. Exp. Med. 2000, 192:1625-1636.
12. Ju Y.J., Park J.E., Juhn K.M., Jeong J., Yun M., Park M.J., Park G.H., Choi K.Y., Cho M.H., Wong K.K., Park W.B., Lee K.H. Chromosomal end fusion resulting from telomere erosion increases susceptibility to radiation via multinucleation: effect of p53. Int. J. Oncol. 2006, 29:753-763.
13. Petersen S., Saretzki G., von Zglinicki T. Preferential accumulation of single-stranded regions in telomeres of human fibroblasts. Exp. Cell. Res. 1998, 239:152-160.
14. Blasco M.A., Lee H.W., Hande M.P., Samper E., Lansdorp P.M., DePinho R.A., Greider C.W. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997, 91:25-34.
15. Garagna S., Marziliano N., Zuccotti M., Searle J.B., Capanna E., Marziliano N. Pericentromeric organization at the fusion point of mouse Robertsonian translocation chromosomes. Proc. Natl. Acad. Sci. USA 2001, 98:171-175.
16. Greenberg R.A., Chin L., Femino A., Lee K.H., Gottlieb G.J., Singer R.H., Greider C.W., DePinho R.A. Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell 1999, 97:515-525.
17. Griffiths S.D., Clarke A.R., Healy L.E., Ross G., Ford A.M., Hooper M.L., Wyllie A.H., Greaves M. Absence of p53 permits propagation of mutant cells following genotoxic damage. Oncogene 1997, 14:523-531.
18. Havre P.A., Yuan J., Hedrick L., Cho K.R., Glazer P.M. P53 inactivation by HPV16 E6 results in increased mutagenesis in human cells. Cancer Res. 1995, 55:4420-4424.
19. Hackett J.A., Feldser D.M., Greider C.W. Telomere dysfunction increases mutation rate and genomic instability. Cell 2001, 106:275-286.
20. Hemann M.T., Strong M.A., Hao L.Y., Greider C.W. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 2001, 107:67-77.
21. Cesare A.J., Kaul Z., Cohen S.B., Napier C.E., Pichett H.A., Neumann A.A., Reddel R.R. Spontaneous occurrence of telomeric DNA damage response in the absence of chromosome fusions. Nat. Struct. Mol. Biol. 2009, 16:1244-1251.
22. Koo C.M., Carrasco D.R., Bosenberg M.W., Paik J.H., DePinho R.A. Ink4a/Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse. Proc. Natl. Acad. Sci. USA 2007, 104:3931-3936.
23. ARF. Cell 1997, 91:649-659.
24. Chin L., Artandi S.E., Shen Q., Tam A., Lee S.L., Gottlieb G.J., Greider C.W., De Pinho R.A. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 1999, 97:527-538.
25. Karlseder J., Broccoli D., Dai Y., Hardy S., De Lange T. P53 and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 1999, 283:1321-1325.
26. Elmore L.W., Rehder C.W., Di X., McChesney P.A., Jackson-Cook C.K., Gewirtz D.A., Holt S.E. Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction. J. Biol. Chem. 2002, 277:35509-35515.